CatalystPit
TerminalPit ConsensusInsidersPoliticiansInstitutionsNewsScreener

BCRXBIOCRYST PHARMACEUTICALS INC

NASDAQ · Biological Products, (No Diagnostic Substances)
Last close $8.33 · 2026-09-30
ABOUT
ExchangeNASDAQ
SectorHealthcare
IndustryBiological Products, (No Diagnostic Substances)
Market cap$2.13B
RECENT INSIDER TRADES
  • 2026-09-02 · McKee Amy E (Director) · OTHER
  • 2026-09-02 · Milne Jill C. (Director) · OTHER
  • 2026-09-02 · Frank Steven (Director) · OTHER
  • 2026-09-02 · MILANO VINCENT (Director) · OTHER
  • 2026-09-02 · Stonehouse Jon P (Director) · OTHER
INSTITUTIONAL OWNERSHIP
Institutional holders341
Shares held326,522,980
Value$3.05B
Percent of shares outstanding127.78%
As of quarter end2026-06-30
RECENT CONGRESSIONAL TRADES
  • 2026-07-10 · Gilbert Cisneros · BUY · $1,001 - $15,000
  • 2026-07-09 · Gilbert Cisneros · BUY · $1,001 - $15,000
RECENT NEWS
  • BioCryst Pharmaceuticals presents at Morgan Stanley healthcare conference
CatalystPit
FeaturesComing soonPricingComing soonPrivacyTermsDisclaimerAffiliate TermsContact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS